• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate.

作者信息

Roffler S R, Wang S M, Chern J W, Yeh M Y, Tung E

机构信息

Institute of Biomedical Sciences, Academia Sinica Taipei, Taiwan, R.O.C.

出版信息

Biochem Pharmacol. 1991 Oct 24;42(10):2062-5. doi: 10.1016/0006-2952(91)90612-9.

DOI:10.1016/0006-2952(91)90612-9
PMID:1741786
Abstract
摘要

相似文献

1
Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate.
Biochem Pharmacol. 1991 Oct 24;42(10):2062-5. doi: 10.1016/0006-2952(91)90612-9.
2
Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy.用于癌症治疗的抗体靶向酶偶联物对葡糖醛酸前药的特异性激活。
Cancer Res. 1992 Aug 15;52(16):4484-91.
3
Cure of malignant ascites and generation of protective immunity by monoclonal antibody-targeted activation of a glucuronide prodrug in rats.单克隆抗体靶向激活葡糖醛酸前药对大鼠恶性腹水的治疗及保护性免疫的产生
Int J Cancer. 1997 Nov 4;73(3):392-402. doi: 10.1002/(sici)1097-0215(19971104)73:3<392::aid-ijc14>3.0.co;2-f.
4
Toward antibody-directed "abzyme" prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing.迈向抗体导向的“抗体酶”前药疗法，ADAPT：通过催化抗体激活氨基甲酸酯前药及其在体外对人肿瘤细胞杀伤的应用。
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):799-803. doi: 10.1073/pnas.93.2.799.
5
Novel inhibitors of carboxypeptidase G2 (CPG2): potential use in antibody-directed enzyme prodrug therapy.羧肽酶G2（CPG2）的新型抑制剂：在抗体导向酶前药疗法中的潜在应用。
J Med Chem. 1999 Mar 25;42(6):951-6. doi: 10.1021/jm990004i.
6
Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs.聚乙二醇修饰β-葡萄糖醛酸酶-抗体偶联物用于通过靶向激活葡萄糖醛酸前药进行实体瘤治疗
Cancer Immunol Immunother. 1997 Aug;44(6):305-15. doi: 10.1007/s002620050387.
7
Characterization of an antineoplastic glucuronide prodrug.一种抗肿瘤葡糖醛酸前药的表征
Biochem Pharmacol. 1999 Jul 15;58(2):325-8. doi: 10.1016/s0006-2952(99)00072-6.
8
Efficient clearance of poly(ethylene glycol)-modified immunoenzyme with anti-PEG monoclonal antibody for prodrug cancer therapy.利用抗聚乙二醇单克隆抗体有效清除聚乙二醇修饰的免疫酶用于前药癌症治疗。
Bioconjug Chem. 2000 Mar-Apr;11(2):258-66. doi: 10.1021/bc990147j.
9
Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs.抗体-羧肽酶G2偶联物与酚氮芥前药联合使用的抗肿瘤作用
Br J Cancer. 1995 Nov;72(5):1083-8. doi: 10.1038/bjc.1995.469.
10
New mustard prodrugs for antibody-directed enzyme prodrug therapy: alternatives to the amide link.用于抗体导向酶前药疗法的新型芥子气前药：酰胺键的替代物
J Med Chem. 1996 Mar 1;39(5):1100-5. doi: 10.1021/jm950671l.

引用本文的文献

1
ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.ATIQCTPC：一种能够在体内靶向肿瘤并阻断血栓形成的纳米药物。
Int J Nanomedicine. 2017 Jun 13;12:4415-4431. doi: 10.2147/IJN.S129989. eCollection 2017.
2
Amide-based prodrugs of spermidine-bridged dinuclear platinum. Synthesis, DNA binding, and biological activity.亚精胺桥联双核铂的酰胺类前药。合成、DNA结合及生物活性。
J Med Chem. 2008 Apr 10;51(7):2254-60. doi: 10.1021/jm070813z. Epub 2008 Mar 14.
3
Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug.
通过抗体靶向的葡糖醛酸苷前药酶促激活实现旁观者杀伤肿瘤细胞
Br J Cancer. 1999 Mar;79(9-10):1378-85. doi: 10.1038/sj.bjc.6690221.
4
Targeting enzymes for cancer therapy: old enzymes in new roles.靶向酶用于癌症治疗：旧酶新角色
Br J Cancer. 1994 Nov;70(5):786-94. doi: 10.1038/bjc.1994.400.
5
Antibody-directed enzyme prodrug therapy.抗体导向酶前药疗法
Clin Pharmacokinet. 1994 Nov;27(5):368-76. doi: 10.2165/00003088-199427050-00004.
6
Analysis of antibody-enzyme conjugate clearance by investigation of prodrug and active drug in an ADEPT clinical study.在一项抗体导向酶解前药疗法（ADEPT）临床研究中，通过对前体药物和活性药物的研究分析抗体-酶偶联物的清除情况。
Cell Biophys. 1994;24-25:193-207. doi: 10.1007/BF02789230.
7
A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer.一种单克隆抗体 - β - 葡萄糖醛酸酶偶联物，作为前药表柔比星 - 葡萄糖醛酸苷的激活剂用于癌症的特异性治疗。
Br J Cancer. 1992 Sep;66(3):474-8. doi: 10.1038/bjc.1992.298.